Streetbeat News

Analyst Ratings

BLDP

Wells Fargo analyst Praneeth Satish maintains an Underweight rating on Ballard Power Systems (NASDAQ:BLDP) and lowers the price target from $4 to $3.5.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:23 am

FTRE

B of A Securities analyst Derik De Bruin maintains an Underperform rating on Fortrea Holdings (NASDAQ:FTRE) and raises the price target from $29 to $33.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:21 am

ORCL

B of A Securities analyst Brad Sills maintains a Neutral rating on Oracle (NYSE:ORCL) and raises the price target from $122 to $144.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:18 am

ZYME

Wells Fargo analyst Derek Archila has maintained an Overweight rating on Zymeworks (NASDAQ:ZYME) and increased the price target from $12 to $14.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:17 am

DG

JP Morgan analyst Matthew Boss upgrades Dollar General (NYSE:DG) from Underweight to Neutral and increases the price target from $120 to $158.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:14 am

ANAB

Wedbush analyst David Nierengarten upgrades AnaptysBio (NASDAQ:ANAB) from Neutral to Outperform, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:11 am

KBR

B of A Securities analyst Mariana Perez has maintained a Buy rating on KBR (NYSE:KBR) and increased the price target from $70 to $80.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:11 am

ACAD

Canaccord Genuity analyst Sumant Kulkarni maintains a Buy rating on ACADIA Pharmaceuticals (ACAD) but lowers the price target from $40 to $33.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:09 am

ETRN

Wells Fargo analyst Michael Blum upgraded Equitrans Midstream (ETRN) from Underweight to Equal-Weight and increased the price target from $10 to $12.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:08 am

VYX

Northcoast Research analyst Kartik Mehta has upgraded NCR Voyix (NYSE:VYX) from Neutral to Buy, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:02 am